Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Type 2 diabetes is associated with lower total testosterone (T) levels in cross-sectional studies. However, it is not known whether the defect is primary or secondary. We investigated the prevalence of hypogonadism in type 2 diabetes by measuring serum total T, free T (FT), SHBG, LH, FSH, and prolactin (PRL) in 103 type 2 diabetes patients. FT was measured by equilibrium dialysis. FT was also calculated by using T and SHBG (cFT). Hypogonadism was defined as low FT or cFT. The mean age was 54.7 +/- 1.1 yr, mean body mass index (BMI) was 33.4 +/- 0.8 kg/m(2), and mean HbA1c was 8.4 +/- 0.2%. The mean T was 12.19 +/- 0.50 nmol/liter (351.7 +/- 14.4 ng/dl), SHBG was 27.89 +/- 1.65 nmol/liter, and FT was 0.250 +/- 0.014 nmol/liter. Thirty-three percent of patients were hypogonadal. LH and FSH levels were significantly lower in the hypogonadal group compared with patients with normal FT levels (3.15 +/- 0.26 vs. 3.91 +/- 0.24 mIU/ml for LH and 4.25 +/- 0.45 vs. 5.53 +/- 0.40 mIU/ml for FSH; P < 0.05). There was a significant inverse correlation of BMI with FT (r = -0.382; P < 0.01) and T (r = -0.327; P < 0.01). SHBG correlated inversely with BMI (r = -0.267; P < 0.05) but positively with age (r = 0.538; P < 0.001) and T (r = 0.574; P < 0.001). FT correlated strongly with cFT (r = 0.919; P < 0.001) but not with SHBG. LH levels correlated positively with FT (r = 0.287; P < 0.05). We conclude that hypogonadotropic hypogonadism occurs commonly in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, Dhindsa et al. (9) demonstrated that 33% of men with type 2 diabetes had significantly lower levels of free testosterone measured by equilibrium dialysis, which is the widely accepted most clinically relevant assay for free testosterone.”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Furthermore, it has been reported that testosterone levels are lower in diabetic men compared with nondiabetic subjects (6 -9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“A recent study has demonstrated that free testosterone levels, which are independent of SHBG, are low in one-third of diabetic men (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
In the citing paper
“Most of the studies in diabetic men have defined hypogonadism solely on the basis of testosterone levels (9).”
From Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes (2007) · cites this paper as [9]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“(12) and using a computer program and web site address supplied by Dr.”
MethodLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760 · cited 11×
“We compared the prevalence of hypogonadism in our study (using the same criteria as BLSA) across various age ranges with the prevalence from BLSA.”
ResultInfluentialRole of Brain Insulin Receptor in Control of Body Weight and Reproduction
Brüning, J. C., Gautam, D., Burks, D. J., Gillette, J., Schubert, M., Orban, P. C., Klein, R., Krone, W., Müller-Wieland, D., & Kahn, C. R. (2000) · Science · doi:10.1126/science.289.5487.2122 · Cited by 2,235
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861 · cited 3×
“In the BLSA, the presence of cancer was associated with a greater decline in T levels than that observed with aging alone (23).”
BackgroundDUNN, J. F., NISULA, B. C., & RODBARD, D. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-53-1-58 · Cited by 1,238 · cited 1×
“In the blood of normal men, 44% of total T is bound to SHBG, 2% is unbound [free T (FT)], and 54% circulates bound to albumin and other proteins (9).”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118 · cited 1×
“PRL levels remain constant or either increase or decrease slightly with age (18, 23).”
BackgroundTestosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Serum T levels in the lower range of normal are able to maintain aspects of sexual functions, but muscle strength, muscle size, and fat-free mass increase progressively in a dose-dependent fashion with increase in circulating T concentrations even within the normal range (39, 40).”
BackgroundMorley, J. E., Kaiser, F. E., Perry, H. M., Patrick, P., Morley, P. M. K., Stauber, P. M., Vellas, B., Baumgartner, R. N., & Garry, P. J. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90057-3 · Cited by 830 · cited 2×
“The increase in LH does not correlate with the decrease in T, suggesting an age-related alteration in this feedback mechanism (24, 25).”
Background
Cited by
Items 501–600 of 637
Armeni, E. (2024) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2023.40 · Cited by 3
Khawaji, A. A., El‐Tholoth, H. S., Albarakati, M., Binjabaan, B. A., Alzahrani, A., Althobity, A., Almardawi, A., Bedaiwi, K., & AlNuami, M. (2025) · Urology Annals · doi:10.4103/ua.ua_40_24 · Cited by 1
Impact of Testosterone Deficiency and Testosterone Therapy on Men’s Health
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_13 · Cited by 1
Zhao, Y.-A., Cao, C., Chu, Y.-X., Hua, R., Xu, B., Shen, Q., Fu, X., Yao, Q., & Shao, Y. (2026) · Asian Journal of Andrology · doi:10.4103/aja2025102 · Cited by 1
Zhao, Y., Cao, C., Hua, R., Tan, X., Chu, Y., He, M., Yao, X., Xu, B., Shen, Q., Fu, X., et al. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02922-3 · Cited by 1
Meikle, A. W. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00183-8 · Cited by 1
Miulescu, R. D., Dănoiu, S., Margina, D. M., Paun, S. C., & Poiană, C. (2012) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/v10255-012-0046-9 · Cited by 1
“It is not known whether the defect is primary or secondary [13].”
BackgroundTraitement androgénique des hypoandrismes masculins
Kuhn, J., & Prévost, G. (2013) · La Presse Médicale · doi:10.1016/j.lpm.2013.06.021 · Cited by 1
The clinical importance of testosterone in men with type 2 diabetes
Hackett, G. I. (2010) · Trends in Urology & Men s Health · doi:10.1002/tre.159 · Cited by 1
Clinical and Biochemical Assessment of Hypogonadism in Type 2 Diabetic Men
Talukder, S., Afsana, F., Latif, Z., Pathan, F., Ashrafuzzaman, S., Khan, S., Habib, S., & Saha, S. (2012) · BIRDEM Medical Journal · doi:10.3329/birdem.v1i1.12378 · Cited by 1
Siddique, L. (2014) · Journal of Rawalpindi Medical College · Cited by 1
Testosterone replacement therapy: Take an informed, individualized approach
Coplan, B. H., Spiegel, J. J., Bleaman, I., & Roch, J. (2011) · JAAPA · doi:10.1097/01720610-201101000-00009 · Cited by 1
MEULEMAN, E. J. H., & van Lankveld, J. J. D. M. (2014) · Springer eBooks · doi:10.1007/978-3-662-45018-5_8 · Cited by 1
METABOLI) SYNDROME AND MALE REPRODUCTIVE HEALTH
Burmistrova, T. A., & Zykova, T. A. (2012) · CyberLeninK (CyberLeninka) · Cited by 1
Endocrinology of male sexual dysfunction
Janmohamed, S. G., & Bouloux, P.-M. G. (2016) · Wiley eBooks · doi:10.1002/9781118746509.ch5 · Cited by 2
Adipositas und Hypogonadismus: Resultate der Testosteron-Therapie
Saad, F. (2016) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/s-0037-1617716 · Cited by 2
“Bei Typ-2-Diabetikern wird Hypogonadismus mit einer Prävalenz von bis zu 60 % berichtet (9).”
BackgroundThe Efficacy of Testosterone Ointment on Insulin Resistance in Men with Metabolic Syndrome
Ueshiba, H. (2017) · Journal of Metabolic Syndrome · doi:10.4172/2167-0943.1000225 · Cited by 1
“Bioavailable testosterone fractions (corresponding to free and albumin-bound testosterone) decreases in states of insulin resistance [1,4,7,10].”
BackgroundTiwari, A., & Srivastava, A. (2016) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2016/975 · Cited by 1
La dysfonction érectile du diabétique
Colson, M.-H., Cuzin, B., Faix, A., Grellet, L., & Huyghes, É. (2018) · Sexologies · doi:10.1016/j.sexol.2018.01.011 · Cited by 2
Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks
Hassanabad, M. F., & Fatehi, M. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180731125724 · Cited by 2
The Complex Relationship Between Erectile Dysfunction and Hypogonadism in Diabetes Mellitus
Holland, L., Beilan, J., Tatem, A., & Lipshultz, L. (2019) · Current Sexual Health Reports · doi:10.1007/s11930-019-00216-9 · Cited by 1
Male hypogonadism and pre-diabetes interplay: association or causal interaction? A systematic review
Greco, C., Corleto, R., Ebert, R., Simoni, M., Rochira, V., & Santi, D. (2021) · Metabolism and Target Organ Damage · doi:10.20517/mtod.2021.14 · Cited by 1
Gandhi, R., Kumar, P. R., Pattanaik, S. R., & Sahoo, D. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_39_22 · Cited by 1
“15–17] However, Dhindsa et al. [18] found a prevalence of 33% in the age group of 28–80 years in T2DM patients, which could be due to older population, higher BMI, and criteria of hypogonadism used.”
BackgroundKant, R., Barnwal, S., Yadav, P., Malik, A., & Dhamija, P. (2023) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2023.102764 · Cited by 1
Male Infertility in Diabetes Mellitus: An Insight into the Pathophysiology
Kamrul-Hasan, A. B. M., Aalpona, F. T. Z., Bhat, S., Mondal, S., Dasgupta, A., & Selim, S. (2023) · Bangladesh Journal of Endocrinology and Metabolism · doi:10.4103/bjem.bjem_8_23 · Cited by 3
Düğer, H. (2024) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1387621 · Cited by 1
Treatment of Erectile Dysfunction
Price, D. E., & Hackett, G. I. (2010) · Wiley eBooks · doi:10.1002/9780470682807.ch20 · Cited by 2
Male Sexual and Reproductive Health
Tharakan, T., Minhas, S., & Jayasena, C. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00036-0 · Cited by 1
Low Testosterone in Obesity and Type 2 Diabetes
Winters, S. J., & Krishnasamy, S. S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-103-5_28 · Cited by 1
Disfunzione autonomica gastro-enterica e genito-urinaria
Spallone, V. (2006) · Cineca Institutional Research Information System (Tor Vergata University)
Disorders of Male Sexual Desire
Hackett, G. I. (2008) · Wiley eBooks · doi:10.1002/9781118269978.ch1
“Hypogonadism has been found to occur in about 20% of erectile dysfunction patients and up to 40% of Type 2 diabetics ( Dhinsa et al., 2004 ).”
BackgroundNabunwa, G., Mbwambo, J., Nyongole, O. V., Nyombi, B., & Mteta, K. A. (2014) · East and Central African journal of surgery
The Effect of Testosterone on Metabolic Syndrome and Type 2 Diabetes
Quammen, A. (2010) · CommonKnowledge Research Repository (Pacific University Oregon)
Khan, M. A., Potdar, N., & Konje, J. C. (2021) · Wiley eBooks · doi:10.1002/9781119622215.ch12
Male reproductive function in diabetes mellitus
Rozhivanov, R. V., Parfenova, N. S., & Курбатов, Д. Г. (2009) · Diabetes Mellitus · doi:10.14341/2072-0351-5698
Hirsutism in a Fifty-Eight-Year-Old Woman
Nair, P., & Bhatia, V. (2008) · The Endocrinologist · doi:10.1097/ten.0b013e318188137a
Déficit androgénico y síndrome metabólico
Hernández, J. J. C. (2007) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(07)74065-7
Hypoandrogen–metabolic (HAM) syndrome: an important men's health issue
Gould, D. C. (2007) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2007.03.007
Treatment of Erectile Dysfunction in the Older Diabetic Patient
Sukumar, N., & Basu, A. (2010) · Aging Health · doi:10.2217/ahe.09.82
“5–2% per year [39] and confirmed the findings of previous studies that sex hormone-binding globulin levels increase in this age group.”
BackgroundFarrell, J. A. B., Deshmukh, A., & Baghaie, A. A. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.59
Testosterone and Its Association with Metabolic and Cardiovascular Disease
Corona, G., Rastrelli, G., & Maggi, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_5
Review Testosterone and Erectile Dysfunction
Yassin, A. A., Saad, F., & Schering, B. (2008)
Kar, S. K., Devdutt, J., Kamboj, A., & Varma, R. (2013)
Low Testosterone Levels in Male Patients with Hypertension,
Agarwal, S. K. (2015)
Anemia in Type 2 diabetes-Its occurance and relashionship with duration of diabetes: A pilot study
Jayalakshmi, L., Damodar, K. S., & Chikkanna, S. (2012) · DOAJ (DOAJ: Directory of Open Access Journals)
Short title - Testosterone and Erectile Dysfunction
Yassin, A. A., Saad, F., & Schering, B. (2008)
A summary of the controversy surrounding off-label medications in men’s health
Parker, A., Bruha, M., Akinola, O., & Welliver, C. (2016) · Translational Andrology and Urology · doi:10.21037/tau.2016.03.07 · Cited by 1
“While there are undoubtedly a variety of age related changes (15-19) and medical co-morbidities that predispose men to the problem (20-25),”
BackgroundYou Want Me to Ask About What? Diabetes and Sexual Health
Zubert, T. (2014) · AADE in Practice · doi:10.1177/2325160314537477
Contrasting Testosterone Concentrations in Type 1 and Type 2 Diabetes
Kennedy, L. (2007) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)70020-9
Hipogonadismo asociado a diabetes mellitus 2 con obesidad.
Oloarte, R., & Carlos, J. (2015)
AUTHOR PROOF COPY Not for publication The many faces of testosterone
Bain, J. (2007) · Cited by 1
Montori, V. M., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., & Ronald, S. H. (2010)
Pituitary Gonadal Axis in the Male
Corradi, P. F., Corradi, R. B., & Greene, L. W. (2016)
13. Late Onset Hypogonadism Syndrome
Horie, S. (2013) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.102.914
Коган, М. И., Белоусов, И. И., Khripun, I., Vorobyev, S., Ibishov, H., Dzantieva, E., & Cherny, A. A. (2016) · Medical news of the North Caucasus · doi:10.14300/mnnc.2016.11024
“The risk of ED in patients with T2DM is 3 times higher than the risk of general male population [9, 12].”
Background(2009) · CRC Press eBooks · doi:10.1201/9781420079364.ch3
Optimal treatment strategy for patients with obstructive jaundice of various origins
Aidemirov, A., Shahnazaryan, N., Vafin, A., Михайлович, Ш. А., Roy, S., & Saif, A. (2016) · Medical news of the North Caucasus · doi:10.14300/mnnc.2016.11025
Gianatti, E. (2016) · Minerva Access (University of Melbourne)
Functional Hypogonadism: Diabetes Mellitus, Obesity, Metabolic Syndrome, and Testosterone
Meirelles, R. M. D. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-46086-4_7 · Cited by 1
Disturbi della sessualità nel paziente diabetico
Luca, G., & Calafiore, R. (2017) · L Endocrinologo · doi:10.1007/s40619-017-0276-4
“Tale riduzione del T induce DE sia direttamente (tramite un effetto sulle cellule muscolari ed endoteliali dei corpi cavernosi) che indirettamente attraverso un calo del desiderio sessuale [7].”
BackgroundMetformin and Prostate Cancer among Diabetic Men
Margel, D. (2014) · TSpace (University of Toronto)
Kumar, P. (2017) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v5i6.175
ERECTILE DYSFUNCTION WITHIN THE PATIENTS WITH AUTONOMIC DIABETIC NEUROPATHY
Повелица, Э. А., Курбатов, Д. Г., Доста, Н. И., Vashchenko, E., Малков, А. Б., Parkhomenko, O. V., Shesternya, А. M., Ниткин, Д. М., & Доманцевич, В. А. (2017) · Andrology and Genital Surgery · doi:10.17650/2070-9781-2017-18-2-15-26
Characterizing the Role of Insulin Signalling in Advanced Prostate Cancer
Sarkar, P. L. (2017) · Queensland University of Technology · doi:10.5204/thesis.eprints.110524
Pinhas‐Hamiel, O., Zeitler, P. S., & Kelsey, M. M. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_24
Plasma Kisspeptin Levels In Type 2 Diabetic Males At The Korle-Bu Teaching Hospital
Kwao‐Zigah, G. (2017)
Sexual dysfunction and treatment approaches
Muhammed, O. S., & Ahmed, K. (2018) · Journal of Pharmacy & Pharmaceutics · doi:10.15436/2377-1313.18.1785
Effects of testosterone levels on mortality and cardiovascular risk in men with Type 2 diabetes
Muraleedharan, V. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York) · Cited by 1
Рівень прозапальних лімфокінів і гормонів у чоловіків, хворих на цукровий діабет 2-го типу
Luchytskyi, V. Y. (2019) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.15.1.2019.158689
Luchytskyi, V. Y., & Лучицький, Є. В. (2018) · Family Medicine · doi:10.30841/2307-5112.6.2018.169885
Asafu-Adjei, D. A., & Gittens, P. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-32300-4_70
Dysfunction of Sexual and Accessory Sex Organs
Kelkar, S. (2020) · Springer eBooks · doi:10.1007/978-981-15-2417-2_6
Combination Therapy for Erectile Dysfunction
Антонян, И. М., & Мошель, Ф. Г. (2018) · Health of Man · doi:10.30841/2307-5090.4.2018.170811
Testosterone Deficiency Evaluation, Management, and Treatment Considerations
Mitchell, K. A. (2020) · Springer eBooks · doi:10.1007/978-3-030-45267-4_2
Obesity and Male Osteoporosis: Protective Factor?
Greco, E. A., Mocini, E., Marocco, C., Lenzi, A., & Migliaccio, S. (2020) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-96376-1_12
Maduka, I. C., & Nnamdi Ngozika, A. (2018) · International Journal of Research -GRANTHAALAYAH · doi:10.29121/granthaalayah.v6.i8.2018.1257
“This observation was also seen in the works of other investigators (Saudeep et al., 2004; Natah et al. 2013, Onah et al., 2013).”
ResultMechanisms of skeletal fragility in diabetes mellitus
Mizokami‐Stout, K., & Clines, G. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820605-8.00003-6
Pakhomova, A. V., Pershina, О. V., Nebolsin, V. E., Ermakova, N. N., Krupin, V. A., Sandrikina, L. A., Pan, E. S., Widera, D., Дыгай, А. М., & Skurikhin, Е. G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.562358 · Cited by 1
“Since hypogonadism can exacerbate metabolic disorders (Kupelian et al., 2006; Selvin et al., 2007; Ebrahimi and Christ-Crain, 2016; Lamm et al., 2016), the relationship between metabolic disorders and hypogonadism is bi-directional (Dhindsa, 2004; Kupelian et al., 2006).”
BackgroundTestosterone and the aging male: To treat or not to treat?
Baina, J. (2010)
A perspective on diabetes-related hypogonadism
Tripathi, S., Elakiya, M., Mishra, A., & Sherrif, D. S. (2021) · Current Medicine Research and Practice · doi:10.4103/cmrp.cmrp_3_21
Erectile dysfunction in men with diabetes (literature review) Part 1
Luchytskyy, E. V., & Luchytskiy, V. (2021) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.17.5.2021.241523
Pavlova, Z. S., Иванович, Г. И., Orlova, Y. A., & Kamalov, A. A. (2021) · Obesity and metabolism · doi:10.14341/omet12733
Makaya, T., Varughese, R., Ryan, F. J., & Pal, A. (2021) · Trends in andrology and sexual medicine · doi:10.1007/978-3-030-80015-4_5
Hashim, N. A., AL-ALI, Z. A. J. R., Syhood, A. A., & Khion, H. (2021) · Materials Today Proceedings · doi:10.1016/j.matpr.2021.09.486
RetractedSaad, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_9
Correct answers to multiple choice questions appearing in the European Urology Update Series 2005
(2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05978.x
Dhindsa, S. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch85
Self-citation(2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.02.033
Male Reproductive Organ and Sexual Differentiation Testing
(2009) · CRC Press eBooks · doi:10.1201/9781420079364.ch9
McKee, A. M., & Morley, J. E. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198701590.003.0148
Brock, G. B., & Harper, W. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.07.038
(2013) · Andrologie · doi:10.1007/12610.1760-5377
Janjgava, S., Zerekidze, T., Uchava, L., Giorgadze, E., & Asatiani, K. (2014) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2014.107
Potdar, N., & Konje, J. C. (2012) · Wiley eBooks · doi:10.1002/9781444398854.ch12
Hypogonadism in patients with type 2 diabetes
(2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0081
Chapter 31: Common Comorbidities
Cypress, M., & Spollett, G. R. (2017) · American Diabetes Association eBooks · doi:10.2337/9781580405690.ch31
UROGENITAL FORM OF DIABETIC AUTONOMOUS NEUROPATHIES: PREVALENCE, ETIOPATHOGENESIS, DIAGNOSTICS
Кравчун, Н. А., & Tkachuk, E. Y. (2012) · PROBLEMS OF ENDOCRINE PATHOLOGY · doi:10.21856/j-pep.2012.2.013
Functional Hypogonadism: Diabetes Mellitus, Obesity, Metabolic Syndrome, and Testosterone
Meirelles, R. M. D. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-31501-5_8
Metadata
- Authors
- Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P.
- Affiliations
- Kaleida Health (US)
- Corresponding author
- Dandona, Paresh
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2004-11
- Volume
- 89
- Issue
- 11
- Pages
- 5462-5468
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2161417745
- Semantic Scholar
- 7eedeed5e563a3df27e91e79ee34ce6e496a93e3
- Cited by
- 631
- References
- 44
- Citations by year
- 2026: 18 · 2025: 16 · 2024: 17 · 2023: 14 · 2022: 24 · 2021: 37 · 2020: 19 · 2019: 27 · 2018: 40 · 2017: 36 · 2016: 37 · 2015: 36 · 2014: 42 · 2013: 43 · 2012: 38
- FWCI
- 9.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- type 2 diabetes, testosterone, free testosterone, sex hormone-binding globulin, luteinizing hormone, follicle-stimulating hormone, prolactin, body mass index, prevalence, hyperandrogenism, insulin resistance, HbA1c
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Follicle Stimulating Hormone, Humans, Hypogonadism, Luteinizing Hormone, Male, Middle Aged, Sex Hormone-Binding Globulin, Testosterone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.